GB:THAT Stock Latest News
Company AnnouncementsThalia Therapeutics Accelerates RNA Strategy With Sanmirna Deal and Clinical-Stage Pipeline1M ago
Company AnnouncementsThalia Therapeutics Secures Chinese Patent for Lead AML Drug miRisten1M ago
Company AnnouncementsThalia Therapeutics Advances Dual-Target RNA Cardiovascular Drug THAT-0021M ago- Company AnnouncementsThalia Therapeutics Advances RNA Portfolio After Strategic Transformation1M ago
Company AnnouncementsThalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances3M ago
Company AnnouncementsThalia Therapeutics Grants Major Director Option Package Tied to Share Price Targets3M agoCompany AnnouncementsThalia Therapeutics Completes Sanmirna Deal and Enlarges Capital Base After AGM3M ago
Company AnnouncementsThalia Therapeutics Targets Clinical-Stage Growth With Sanmirna Deal and RNA Pipeline Push3M ago
Company AnnouncementsThalia Therapeutics Sets AGM to Vote on Sanmirna Acquisition and Fundraise4M ago
Company AnnouncementsThalia Therapeutics buys Sanmirna and raises £2.75m to fast-track AML RNA therapy4M ago
Company AnnouncementsThalia Therapeutics pivots to RNA therapeutics as Nuvec platform advances toward clinic4M ago
Company AnnouncementsThalia Therapeutics Showcases RNA Strategy in European Biotech Feature4M ago
Company AnnouncementsThalia Therapeutics Showcases Differentiated RNA Strategy and Cardiovascular Candidate5M agoCompany AnnouncementsThalia Therapeutics CEO Outlines Strategic Pivot to High-Value RNA Therapies5M ago
